July 13, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced it has received National Ethics Committee approval in the Democratic Republic of the Congo (“DRC”) for a Phase II clinical trial evaluating its NV-387 oral gummies as a treatment for the current Bundibugyo ebolavirus outbreak.
July 13, 2026 — Affordability and accessibility remain the company’s core priorities as it expands its surgical robotics platform globally, with artificial intelligence, automation, and new robotic platforms, remaining central to the company’s long-term product roadmap. Telesurgery and teleproctoring are becoming important differentiators, allowing expert surgeons to support complex procedures remotely.
July 13, 2026 — Wrap Technologies (NASDAQ: WRAP) is featured in a new NetworkNewsAudio audio press release titled, “Lock the Sensor, Lock the Response: The Power of Building the Autonomous Public-Safety Stack. ” The editorial highlights the company’s integration of Frenel Imaging’s TPiCore thermal polarimetric imaging technology into its WrapShield platform, providing exclusive rights across the United States and NATO markets to support real-time detection of RF-silent threats for public safety, defense and critical infrastructure applications.
July 13, 2026 — Safe Pro Group (NASDAQ: SPAI) announced it has been selected by AFWERX for a Small Business Innovation Research (“SBIR”) contract to develop a new artificial intelligence dataset using images of foreign object debris and damage (“FOD”) commonly found on U. S.
July 13, 2026 — Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.
July 13, 2026 — Safe Pro Group (NASDAQ: SPAI) announced it has been selected by AFWERX for a Small Business Innovation Research (“SBIR”) contract to develop a new artificial intelligence dataset using images of foreign object debris and damage (“FOD”) commonly found on U. S.
July 13, 2026 — Olenox Industries (NASDAQ: OLOX) announced the completion of its acquisition of PsyLinks Neurotech Corp. , which will operate as a wholly owned subsidiary following the transaction.
July 13, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) announced a major managed Medicare agreement for TONMYA(R) (cyclobenzaprine HCl sublingual tablets), adding approximately 9 million Medicare beneficiaries effective Jan. 1, 2027.
July 13, 2026 — Xeriant (OTCQB: XERI) announced additional independent laboratory testing showing its 3/8-inch NEXBOARD eco-composite construction panel outperformed traditional building materials, including drywall, MgO board, OSB, MDF and plywood, across multiple performance categories. The company said the latest results demonstrated superior impact resistance, tensile strength and water resistance while confirming low VOC emissions, competitive insulating properties and a sustainability profile that includes recycled content, recyclability and no formaldehyde off-gassing.
July 13, 2026 — AINewsWire Editorial Coverage: The AI buildout is usually described in one word: chips. But the more revealing story may be happening downstream in the specialty automation, robotics and semiconductor production equipment needed to build and package those chips at scale.
July 13, 2026 — Artificial intelligence (AI) is changing the way people work in many countries. A new Microsoft report shows that workers in Switzerland are getting more value from AI than workers in many other parts of the world.
July 13, 2026 — A research team investigating children’s brain tumors has found promising results combining a hormone treatment with standard chemotherapy protocols. Triiodothyronine, commonly called T3, is a medication long used to manage thyroid disorders in patients throughout the lifespan.
July 13, 2026 — You may have read in the news how many central banks ranging from Germany, Poland, India, Russia and Brazil have been moving their gold reserves from the New York Fed and London to vaults that they own domestically. As an investor, you may be wondering what implications this trend has for the trajectory of your gold holdings and how you should respond to this accelerating phenomenon.
July 13, 2026 — You may have read in the news how many central banks ranging from Germany, Poland, India, Russia and Brazil have been moving their gold reserves from the New York Fed and London to vaults that they own domestically. As an investor, you may be wondering what implications this trend has for the trajectory of your gold holdings and how you should respond to this accelerating phenomenon.
July 13, 2026 — Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is featured in an AINewsWire editorial examining how the AI infrastructure buildout is driving demand beyond chips to the specialty automation, robotics and semiconductor production equipment needed to support manufacturing at scale. The editorial highlights Nightfood’s proposed dual-region manufacturing expansion with strategic partner Jiun Jiang Enterprise Co.
July 13, 2026 — Talent Acquisition Week(R), a leading virtual event for recruitment and HR leaders, is scheduled to take place this summer from July 27 to 30, 2026. This much-awaited gathering will bring together sourcing experts, recruiters, HR and employer branding experts, for an immersive virtual learning experience.
July 13, 2026 — VERAXA Biotech (NASDAQ: VRXA) announced a collaboration with AI-driven bioinformatics company Ardigen S. A.
July 13, 2026 — Wrap Technologies (NASDAQ: WRAP) announced it entered the third quarter of 2026 with approximately $1. 2 million in international orders from customers in Brazil and India, with the associated revenue expected to be recognized during the quarter.
July 13, 2026 — A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announced the appointment of Gadi Levin as chief financial officer, effective immediately.
July 13, 2026 — This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced the successful completion of its analytical reference standard preparation program for A83B4C63, the active pharmaceutical ingredient supporting its lead oncology candidate, ONC010.